COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding
Background/Purpose: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is common in critically ill patients with COVID-19 and is associated with worse outcomes. However, reports on CAPA and its impact on treatment outcomes in Asian populations are limited. Methods: Patient...
Main Authors: | Jhong-Ru Huang, Hsiao-Chin Shen, Chuan-Yen Sun, Wei-Chih Chen, Yuh-Min Chen, Jia-Yih Feng, Kuang-Yao Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664622002790 |
Similar Items
-
Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2
by: Weijie Zhong, et al.
Published: (2023-01-01) -
Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
by: Florian Reizine, et al.
Published: (2021-05-01) -
Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
by: Robbert G. Bentvelsen, et al.
Published: (2022-01-01) -
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience
by: Alessandro Russo, et al.
Published: (2024-01-01) -
Clinical Outcomes and Prolonged SARS-CoV-2 Viral Shedding in ICU Patients with Severe COVID-19 Infection and Nosocomial Bacterial Pneumonia: A Retrospective Cohort Study
by: Chuan-Yen Sun, et al.
Published: (2022-11-01)